title: A post-partum hemolytic-uremic-like-syndrome in a patient with pre-eclampsia: description of a clinical case.
abstract: HEMOLYTIC UREMIC SYNDROME POST-PARTUM: We describe a case of a 37-year-old woman admitted for severe renal failure to our hospital immediately after the delivery by caesarean section of twins. She had anuria, anemia, and moderate thrombocytopenia. A diagnosis of hemolytic-uremic syndrome was made. Plasma exchange was started, substitution was performed with fresh frozen plasma and eight consecutive plasmapheresis sessions were given. She received hydrocortisone and ACE inhibitors. After about fifteen days from the beginning of the illness, signs of active haemolysis disappeared and renal function was partially recovered. A genetic study demonstrated the absence of HF1 and MCP mutations but a polymorphic variant of the HF1 gene (C-257T promoter region). This polymorphism is strongly associated with non-diarrhoea-HUS (D-HUS). Post-partum HUS is quite a rare syndrome and has a poor outcome; however prompt diagnosis and efficacious therapy could save lives without clinical consequences. The excellent outcome of this patient seems to corroborate this concept.
authors.affiliation: Nephrology and Dialysis Unit, A.Cardarelli Hospital, Naples, Italy. rosariaian@libero.it
authors.forename: Mariarosaria
authors.initials: M
authors.lastname: Iannuzzi
authors.forename: Patrizia
authors.initials: P
authors.lastname: Siconolfi
authors.forename: Antonio
authors.initials: A
authors.lastname: D'Angelillo
authors.forename: Maria
authors.initials: M
authors.lastname: Capuano
authors.forename: Luigi
authors.initials: L
authors.lastname: Tufano
authors.forename: Michela
authors.initials: M
authors.lastname: Macri
mesh_terms: D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D017242:Complement Factor H / Q000235:genetics / Q000378:metabolism; D005260:Female; D006461:Hemolysis; D006463:Hemolytic-Uremic Syndrome / Q000175:diagnosis*; D006801:Humans; D006854:Hydrocortisone; D051916:Membrane Cofactor Protein / Q000235:genetics; D010951:Plasma Exchange / Q000379:methods; D010956:Plasmapheresis; D011110:Polymorphism, Genetic; D049590:Postpartum Period; D011225:Pre-Eclampsia / Q000628:therapy*; D011247:Pregnancy; D011401:Promoter Regions, Genetic; D051437:Renal Insufficiency / Q000628:therapy; D013927:Thrombosis
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D051916:Membrane Cofactor Protein; D017242:Complement Factor H; D006854:Hydrocortisone